A case of membranous nephropathy diagnosed with lupus nephritis 11 years after onset

CEN Case Rep. 2019 Nov;8(4):301-307. doi: 10.1007/s13730-019-00412-5. Epub 2019 Aug 9.

Abstract

A 34-year-old female patient presented to our hospital with lower extremity edema and proteinuria during pregnancy. Renal biopsy was performed and the patient was diagnosed with nephrotic syndrome due to lupus-like membranous nephropathy. This diagnosis was reached upon as laboratory findings upon admission, wherein both anti-nuclear and anti-double-stranded DNA antibodies revealed negative, did not fulfill the criteria for systemic lupus erythematosus (SLE) proposed by the American College of Rheumatology (ACR) and the patient did not reveal any typical physical manifestations of SLE. Methylprednisolone pulse therapy was started followed by oral administration of prednisolone. Urinary protein excretion diminished after 1 year of treatment. Eleven years later, the same patient was admitted to our hospital again with relapse of nephrotic syndrome. Laboratory findings upon second admission, wherein both anti-nuclear and anti-double-stranded DNA antibodies revealed positive, fulfilled the ACR criteria. Renal biopsy was performed again, resulting in a diagnosis of lupus nephritis. Steroid therapy combined with administration of mycophenolate mofetil led to an incomplete remission. Immunofluorescence studies confirmed the presence of IgG, IgM, C3, and C1q in renal biopsy specimens both at first and second admissions. Furthermore, immunofluorescence studies confirmed the presence of IgG1-4 in the first biopsy and tubuloreticular inclusions (TRIs) were revealed using electron microscopy. The present case represents the possibility that characteristic pathological findings of lupus nephritis, including TRIs, can reveal themselves before a diagnosis of SLE.

Keywords: IgG subclass; Lupus-like membranous nephropathy; Membranous lupus nephritis; Tubuloreticular inclusion.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antibodies, Antinuclear / blood
  • Drug Therapy, Combination / methods
  • Enzyme Inhibitors / administration & dosage
  • Enzyme Inhibitors / therapeutic use
  • Female
  • Glomerulonephritis, Membranous / diagnosis*
  • Glomerulonephritis, Membranous / immunology
  • Glomerulonephritis, Membranous / pathology
  • Glucocorticoids / administration & dosage
  • Glucocorticoids / therapeutic use
  • Hospitalization
  • Humans
  • Immunoglobulin G / blood
  • Immunoglobulin G / classification
  • Kidney / immunology
  • Kidney / pathology
  • Kidney / ultrastructure
  • Lupus Erythematosus, Systemic / diagnosis*
  • Lupus Nephritis / complications
  • Lupus Nephritis / immunology
  • Lupus Nephritis / pathology
  • Methylprednisolone / administration & dosage
  • Methylprednisolone / therapeutic use
  • Mycophenolic Acid / administration & dosage
  • Mycophenolic Acid / therapeutic use
  • Nephrotic Syndrome / drug therapy
  • Nephrotic Syndrome / pathology*
  • Proteinuria / diagnosis*
  • Recurrence
  • Remission Induction

Substances

  • Antibodies, Antinuclear
  • Enzyme Inhibitors
  • Glucocorticoids
  • Immunoglobulin G
  • Mycophenolic Acid
  • Methylprednisolone